Pinnacle Biologics delivers photodynamic therapy (PDT) to patients through its proprietary line of products. By administering a unique FDA approved biopharmaceutical drug that is selectively retained in tumors and activated by a specific FDA approved laser light, PDT can eradicate tumor cells. The two primary uses for Pinnacle’s drug include the treatment of esophageal cancer and the treatment of non-small cell cancer (NSCLC). Both indications are supported by national treatment guidelines.